SCHEMBL24946340

SCHEMBL24946340

CN[C@]1(C(F)(F)F)CC[C@H](O)CC1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21843741 1.00 SLC6A4 (0.36) SLC6A4SLC6A3
SCHEMBL15612914 0.80
Hydrochloric Acid SCHEMBL28506550 0.78
SCHEMBL21843743 0.77 SLC6A4 (0.31) SLC6A4
SCHEMBL21917419 0.77 SLC6A4 (0.31) SLC6A4
SCHEMBL28284191 0.75
SCHEMBL17469451 0.75
SCHEMBL21843739 0.74 SLC6A4 (0.30) SLC6A4
Hydrochloric Acid SCHEMBL28907100 0.73
SCHEMBL24946337 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11566001-B2 Hepatitis B capsid assembly modulators VenatoRx Pharmaceuticals, Inc. (US) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566001-B2 Hepatitis B capsid assembly modulators HAVCR2, COPB1, HDLBP SLC6A4 4861/4885SLC6A3 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.